Anatara Lifesciences Ltd (AU:ANR) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Anatara Lifesciences Limited has announced a change in director David Brookes’ interest in the company’s securities, with the acquisition of 500,000 ordinary shares through his Brookes Superfund and Dahlbrook Family Trust for $25,000. This update may interest investors tracking the company’s leadership and stock movements.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue